A detailed history of Elco Management Co., LLC transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Elco Management Co., LLC holds 12,000 shares of LCTX stock, worth $6,480. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,000
Previous 12,000 -0.0%
Holding current value
$6,480
Previous $12,000 16.67%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$1.02 - $1.5 $12,240 - $18,000
12,000 New
12,000 $14,000
Q3 2022

Nov 14, 2022

BUY
$1.13 - $1.77 $13,559 - $21,240
12,000 New
12,000 $14,000

Others Institutions Holding LCTX

About Lineage Cell Therapeutics, Inc.


  • Ticker LCTX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 169,755,008
  • Market Cap $91.7M
  • Description
  • Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...
More about LCTX
Track This Portfolio

Track Elco Management Co., LLC Portfolio

Follow Elco Management Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Elco Management Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Elco Management Co., LLC with notifications on news.